Neurotech Clinical Trials
NeurotechMag Pro tracks clinical trials across brain computer interfaces, neural implants, neurostimulation and neuroimaging. Click any study for a short preview. Showing the latest 48 of 115 tracked records.
Recent clinical trials
ClinicalTrials.gov · Oct 31, 2026
Restoring Speech With an Intracortical Neuroprosthesis for Post-Stroke Agrammatic Aphasia
This study continues development of an intracortical brain-computer interface to restore speech in stroke survivors with agrammatic aphasia, a language disorder that limits the ability to speak. It plans to enroll 2 participants, with the registry listing…
ClinicalTrials.gov · Sep 18, 2026
Effects of Rehabilitation Enriched With Transcutaneous Auricular Vagus Nerve Stimulation on Lower Extremity Function, Pain, and Quality of Life in Individuals With Lipedema
Istanbul University-Cerrahpasa is recruiting 30 people with lipedema for a study of rehabilitation (aerobic exercise and complex decongestive therapy) with active or sham transcutaneous auricular vagus nerve stimulation. It measures leg function, pain and…
ClinicalTrials.gov · Jun 1, 2026
Effects of Different Frequencies of Transauricular Vagus Nerve Stimulation on Postoperative Pain: A Randomized, Double-Blind, Sham-Controlled Trial With Preoperative and Postoperative Sessions
The Federal University of Bahia in Brazil is recruiting 174 patients for a sham-controlled trial that compares high and low frequencies of transauricular vagus nerve stimulation for pain after surgery. Opioid use is among the outcomes.
ClinicalTrials.gov · May 20, 2026
Effects of Non-invasive Auricular Vagus Nerve Stimulation (taVNS) on Postural Control and Autonomic Responses in Stroke Patients
Riphah International University in Pakistan is recruiting 22 stroke patients for a randomized study of transcutaneous auricular vagus nerve stimulation combined with balance training. Outcomes include postural control and autonomic responses.
ClinicalTrials.gov · May 6, 2026
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
Peking University People's Hospital plans a 216-patient study of transcutaneous auricular vagus nerve stimulation, with sham stimulation as the comparator, for joint and muscle pain caused by aromatase inhibitors in breast cancer. The sponsor's title also…
ClinicalTrials.gov · May 1, 2026
A Prospective, Randomized, Parallel-Controlled Clinical Study Protocol of Non-Invasive Brain Computer Interface Robot Based on Mirror Rehabilitation Theory in the Treatment of Upper Limb Motor Function Disorder After Stroke
This randomized trial combines a non-invasive brain-computer interface with a robotic mirror-therapy system to help stroke patients with severely impaired upper-limb motor function. The approach aims to induce compensatory movements on the healthy side and…
ClinicalTrials.gov · May 1, 2026
The Effect of Transcranial Electrical Stimulation Combined With Transcranial Magnetic Stimulation on Cognitive Impairment and Motor Function After Stroke
A randomized, parallel-group study in China will combine transcranial electrical stimulation with TMS in 24 stroke patients, with cognition and motor function as the targets. The registry lists it as not yet recruiting, with an estimated start in May 2026.
ClinicalTrials.gov · Apr 27, 2026
Transcranial Magnetic Stimulation for Postoperative Delirium After Cardiac Surgery: A Prospective, Single-Center, Randomized Double-Blind Controlled Study
RenJi Hospital in Shanghai plans a 144-patient randomized, sham-controlled study of theta burst stimulation for delirium after cardiac surgery. The registry lists the study as not yet recruiting, with an estimated start in April 2026 and completion in…
ClinicalTrials.gov · Apr 21, 2026
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
The long-running BrainGate2 multi-site feasibility study continues enrolling ALS, brainstem stroke, and SCI patients at 5 US academic centers. Participants receive implanted Utah Array BCIs and participate in sessions using neural signals to control computers.
ClinicalTrials.gov · Apr 20, 2026
FIH Clinical Investigation of Graphene Electrodes for Brain Mapping
The completed enrollment phase of INBRAIN Neuroelectronics' first-in-human study of their graphene cortical interface at Salford Royal Hospital, Manchester. Ten patients recruited, eight surgically treated during brain tumor resection procedures with no…
ClinicalTrials.gov · Apr 19, 2026
Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary Syndrome (HEART-SET-3)
HEART-SET-3 is a randomized, sham-controlled, double-blinded trial of closed-loop neurofeedback using functional near-infrared spectroscopy (fNIRS), targeting the right dorsolateral prefrontal cortex. It aims to enroll 214 patients with chronic coronary…
ClinicalTrials.gov · Apr 18, 2026
A Randomized, Double-blind, Sham-controlled Pivotal Study of Sensory Stimulation in Subjects With Alzheimer's Disease (HOPE Study)
Phase 3 trial of Cognito Therapeutics' Spectris wearable (40Hz gamma light and sound, 1 hour/day) in 550 early Alzheimer's patients over 18 months. Primary endpoint: CDR-SB cognitive score change.
ClinicalTrials.gov · Apr 1, 2026
SONIC: Subcallosal Cingulate DBS for Treatment-Resistant Depression (NCT03437928)
Multicenter trial of subcallosal cingulate white matter DBS in 60 severely treatment-resistant depression patients across 6 US sites, using diffusion tractography-guided targeting to identify the optimal stimulation site per individual. Extends Emory's…
ClinicalTrials.gov · Apr 1, 2026
Efficacy of High-Frequency Repetitive Transcranial Magnetic Stimulation in Patients With Post-Stroke Cognitive Impairment: A Randomized Controlled Trial
Qilu Hospital of Shandong University is recruiting 40 patients for a randomized, sham-controlled trial of high-frequency repetitive TMS for cognitive impairment after stroke. The registry lists a start in April 2026 and completion in July 2027.
ClinicalTrials.gov · Mar 31, 2026
Connect-One: Early Feasibility Study of Connexus Brain-Computer Interface (BCI) to Provide Human Connection Through Communication
The Connect-One Study is Paradromics' early feasibility study of the Connexus Brain-Computer Interface for patients with impaired communication due to ALS, stroke, or other neuromuscular diseases. The Connexus BCI is a high-data-rate cortical implant…
ClinicalTrials.gov · Mar 26, 2026
Biomarkers of Paired Vagus Nerve Stimulation Therapy for Stroke Motor Rehabilitation
MGH Institute of Health Professions in the US is recruiting 50 participants for a study of biomarkers linked to paired vagus nerve stimulation for motor recovery after ischemic stroke. The registry lists a start in March 2026 and completion in October 2029.
ClinicalTrials.gov · Mar 17, 2026
Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke
) is suitable for a six-month intensive rehabilitation program using Brain-Machine Interface. * A second phase, consisting of implementing the intensive rehabilitation program, first in the traditional manner, without the Brain-Machine Interface (2 to 5…
ClinicalTrials.gov · Mar 2, 2026
Non-invasive Vagus Nerve Stimulation (nVNS) for Adjunctive Treatment of Symptoms Associated With Post-Traumatic Stress Disorder (PTSD)
This open-label pilot tests whether electroCore's handheld gammaCore non-invasive vagus nerve stimulator is safe and helps as an added treatment for post-traumatic stress disorder in adults. It plans to enroll 40 participants in California and began in…
ClinicalTrials.gov · Feb 28, 2026
Effect of Intraoperative Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium and Negative Emotional States in Patients Undergoing Cardiac Surgery: A Multicenter, Randomized, Double-Blind, Sham-Controlled Trial
The Chinese PLA General Hospital plans a 270-patient, multicenter, sham-controlled trial of transcutaneous auricular vagus nerve stimulation during cardiac surgery. It targets postoperative delirium, anxiety and depression.
ClinicalTrials.gov · Jan 1, 2026
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
The INTENT study evaluates a high-bandwidth neural interface system developed by Johns Hopkins University for individuals with tetraplegia, ALS, and other neuromuscular disorders. The system aims to enable direct brain control of external devices including…
ClinicalTrials.gov · Dec 15, 2025
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
This study evaluates passive neurosensory reintegration training as a tool to augment mild traumatic brain injury recovery. The non-invasive neuromodulation device delivers specific patterns of sensory stimulation designed to promote neural reorganization…
ClinicalTrials.gov · Dec 11, 2025
Empower: tDCS for Major Depressive Disorder at Home — Phase 2 RCT (NCT05202119) — Completed, FDA PMA approved
Flow Neuroscience's completed Phase 2 RCT (NCT05202119) that formed the basis for the December 11, 2025 FDA PMA approval of FL-100. The double-blind, placebo-controlled, randomized superiority trial evaluated at-home tDCS (2mA, 30 min/day, 3-5x/week, 10…
ClinicalTrials.gov · Dec 2, 2025
Clinical Effects of Low-Intensity Focused Ultrasound Neuromodulation in Patients With Neurological and Psychiatric Disorders
This trial investigates the clinical effects of low-intensity focused ultrasound neuromodulation in patients with Parkinson's disease, essential tremor, dystonia, and epilepsy who are candidates for deep brain stimulation surgery. The study uses…
ClinicalTrials.gov · Dec 1, 2025
Functional Outcomes and Control Using Synchron BCI - Australia
This study evaluates the Synchron Stentrode, an endovascular brain-computer interface that is implanted via the jugular vein rather than through open brain surgery. Participants with motor neurone disease (ALS) in Australia will be implanted with the…
ClinicalTrials.gov · Nov 28, 2025
High-Definition Transcranial Direct Current Stimulation (HD-tDCS) in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial
This Phase 2/Phase 3 multicenter randomized controlled trial evaluates high-definition transcranial direct current stimulation (HD-tDCS) in patients with amyotrophic lateral sclerosis. The study delivers targeted non-invasive brain stimulation to the…
ClinicalTrials.gov · Nov 24, 2025
Targeted Accelerated TMS for Post-Traumatic Stress Disorder
Post-traumatic stress disorder (PTSD) is a highly prevalent and debilitating condition among veterans and active-duty military personnel, with rates as high as 30% in certain combat-exposed populations. Conventional treatments such as prolonged exposure…
ClinicalTrials.gov · Nov 14, 2025
Home-Based Transcranial Direct Current Stimulation in Major Depressive Disorder: a Multi-Centre, Two-Parallel Group, Superiority Randomised Controlled Trial
Depression is a prevalent and debilitating disorder. The most common treatments are antidepressant medications and talking therapies.
ClinicalTrials.gov · Nov 12, 2025
A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Transcranial Magnetic Stimulation for Treatment Resistant Depression: The MIND1 Trial
Major depressive disorder (MDD) is a significant public health problem and leading cause of worldwide disability. Treatment resistance is common in MDD, however, for these individuals, targeted noninvasive brain stimulation is an alternative.
ClinicalTrials.gov · Nov 10, 2025
Accelerated High-Dose tDCS for Depression: An Open-Label Outpatient Pilot Study
In this study, investigators are testing whether a higher dose of a non-invasive brain stimulation technique, called transcranial direct current stimulation (tDCS), can be safely used in people with depression. Participants will come to the Brain…
ClinicalTrials.gov · Nov 1, 2025
BCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities (BCI@home)
This study evaluates the use of brain-computer interfaces (BCI) at home for children ages 5-18 with severe physical disabilities including cerebral palsy and pediatric stroke. Participants receive a BCI kit with headset and software, then complete 12…
ClinicalTrials.gov · Nov 1, 2025
Neuronavigated Transcranial Magnetic Stimulation As An Adjunctive Treatment For Chronic Tinnitus
This trial evaluates neuronavigated repetitive transcranial magnetic stimulation as an adjunctive treatment for chronic tinnitus. Using MRI-guided neuronavigation, the study precisely targets the auditory cortex with low-frequency rTMS to suppress…
ClinicalTrials.gov · Oct 20, 2025
Restoration of Central Vision With the PRIMA System in Patients With Atrophic Age-Related Macular Degeneration
The PRIMAvera pivotal clinical trial of Science Corporation's PRIMA retinal BCI implant in 38 patients with geographic atrophy (advanced dry AMD) — the study whose results were published in NEJM October 2025 showing 80% of patients restored functional…
ClinicalTrials.gov · Oct 17, 2025
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
This study evaluates the ARC-IM implantable spinal cord stimulation system for managing symptomatic blood pressure instability secondary to spinal cord injury. The device delivers targeted epidural electrical stimulation to restore autonomic cardiovascular…
ClinicalTrials.gov · Oct 14, 2025
Intracranial Recording and Stimulation of the Human Hippocampal-Amygdala Circuit During Virtual Reality Fear Conditioning
The goal of this clinical trial is to learn how people respond to fear-related experiences in a virtual reality (VR) environment. The study will also look at how brain activity and body responses are connected to learning and memory of fear.
ClinicalTrials.gov · Oct 3, 2025
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
The VOICE study is an early feasibility trial of Neuralink's N1 implant, placed by the R1 surgical robot, to restore the ability to communicate in adults with severe speech impairment. Enrollment is limited to 6 participants with conditions including…
ClinicalTrials.gov · Oct 1, 2025
Effectiveness of Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep
This study evaluates whether repetitive transcranial magnetic stimulation (rTMS) targeting the default mode network can improve sleep quality in adults with chronic insomnia. Participants will receive either active rTMS or sham stimulation over 10 sessions…
ClinicalTrials.gov · Sep 1, 2025
Control of Assistive Devices Via Brain-Computer Interface Technology
This Neuralink-sponsored study evaluates the use of the N1 brain-computer interface implant to enable participants with tetraplegia or ALS to control an assistive robotic arm. Building on the PRIME study, this trial specifically tests BCI-driven control of…
ClinicalTrials.gov · Aug 1, 2025
Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial
This trial analyzes personalized-target transcranial magnetic stimulation for chronic tinnitus using individual neuroimaging-guided targeting. Rather than standardized coil placement, stimulation targets are determined from each patient's own brain imaging…
ClinicalTrials.gov · Aug 1, 2025
Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
This trial evaluates a combined non-invasive brain stimulation and exercise intervention for patients with amyotrophic lateral sclerosis. The study integrates repetitive transcranial magnetic stimulation with structured physical exercise to assess…
ClinicalTrials.gov · Jul 3, 2025
Bilateral Hypoglossal Nerve Stimulation With the XII Medical HGNS System for the Treatment of Adult Obstructive Sleep Apnea Pilot Study
The goal of this interventional study is to assess the safety and performance of the XII Medical Hypoglossal Nerve Stimulation (HGNS) System in people who have moderate to severe Obstructive Sleep Apnea (OSA). Participation in this study involves being…
ClinicalTrials.gov · Jul 1, 2025
Spine and Brain Stimulation for Movement Recovery After Cervical Spinal Cord Injury
This study at Burke Neurological Institute evaluates paired spinal cord and brain stimulation for improving arm and hand function after cervical spinal cord injury. Participants receive epidural spinal cord stimulation combined with non-invasive brain…
ClinicalTrials.gov · Jun 27, 2025
A Randomized, Double-blind, Parallel-arm, Sham-controlled Trial of ElectraRx Mindfulness Transcranial Direct Current Treatment System (Elect-MDS) for Adults With Major Depressive Disorder
This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression. The study involves the use of transcranial direct current…
ClinicalTrials.gov · Jun 8, 2025
Centromedian Deep Brain Stimulation vs. Vagus Nerve Stimulation for the Treatment of Drug-Resistant Epilepsy and Epileptic Spasms in Children: A Randomized Trial
Deep Brain Stimulation vs. Vagus Nerve Stimulation for the Treatment of Drug-Resistant Epilepsy and Epileptic Spasms in Children: A Randomized Control Trial.
ClinicalTrials.gov · Jun 1, 2025
Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
This longitudinal study provides Cognixion's AXON-R headset combining augmented reality, BCI, and AI to late-stage ALS patients for at-home use over 6 months. The system enables hands-free communication and computing control using brain-computer interface…
ClinicalTrials.gov · May 25, 2025
A Prospective, Multi-Center Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface(BCI)System NEO in Patients With Tetraplegia
To evaluate the safety and efficacy of a Minimally Invasive Wireless Implantable Brain-Computer Interface (BCI) System NEO in patients with tetraplegia and to provide a basis for product registration. Through brain-computer interface alternative…
ClinicalTrials.gov · May 19, 2025
Evaluation of the Efficacy of Home-based Transcranial Direct Current Stimulation on Physical Function in Patients With Amyotrophic Lateral Sclerosis: a Randomized, Controlled Clinical Trial
This study evaluates home-based transcranial direct current stimulation (tDCS) delivered through a remote supervision platform for patients with amyotrophic lateral sclerosis. Participants receive daily anodal tDCS sessions targeting the motor cortex while…
ClinicalTrials.gov · May 13, 2025
Perinatal Accelerated iTBS Neuromodulation Therapy
We are studying a treatment for depression called accelerated Transcranial Magnetic Stimulation (TMS) among pregnant and postpartum individuals. TMS is a focal, non-invasive form of brain stimulation that is cleared by the Food and Drug Administration for…
ClinicalTrials.gov · May 1, 2025
Brain Computer Interface (BCI) Integrated Wearable Hand Robotic Glove System for Stroke Rehabilitation
This Singapore-based study integrates a brain-computer interface with the HandyRehab robotic hand glove for stroke rehabilitation. Chronic stroke patients use EEG-based BCI to control robotic-assisted hand movements during therapy sessions.
Want full summaries, analysis and alerts? Create an account or browse the preview.